Kangstem Publishes Promising Phase 1 Results for Cord-Blood Derived Stem Cell Therapy in Knee Osteoarthritis, Post-MRI Data Suggest Potential Cartilage Regeneration
The Korean biotech company published the multicenter Phase 1 results in Nature, with 24-week follow-up MRI data that look promising as they continue development.
Igor Bimbiloski
30.08.2026
The Moderna cancer vaccine offers hope — now we must speed up personalized therapies
A positive trial holds promise for treating people with cancer. More research is needed to get effective vaccines to the clinic.
Igor Bimbiloski
30.08.2026
Sodium-ion batteries are ready for world domination
Sodium battery companies may already be walking the walk, but soon they just might be running away with the energy storage market.
Igor Bimbiloski
30.08.2026